{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:23:04Z","timestamp":1786112584333,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00393-026-01844-y","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:24:18Z","timestamp":1782915858000},"page":"440-449","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pr\u00e4vention der rheumatoiden Arthritis","Prevention strategies in rheumatoid arthritis"],"prefix":"10.1007","volume":"85","author":[{"given":"J\u00fcrgen","family":"Rech","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"1844_CR1","doi-asserted-by":"crossref","unstructured":"Koller-Smith L, et\u00a0al. Rheumatoid Arthritis Is a\u00a0Preventable Disease: 11 Ways to Reduce Your Patients\u2019 Risk. Internal Medicine Journal. 2022.","DOI":"10.1111\/imj.15537"},{"key":"1844_CR2","doi-asserted-by":"crossref","unstructured":"Zaccardelli A, et\u00a0al. Potential of Lifestyle Changes for Reducing the Risk of Developing Rheumatoid Arthritis. Clinical Therapeutics. 2019.","DOI":"10.1016\/j.clinthera.2019.04.021"},{"key":"1844_CR3","doi-asserted-by":"crossref","unstructured":"Maisha JA, et\u00a0al. Modifiable Risk Factors Linked to the Development of Rheumatoid Arthritis. Frontiers in Immunology. 2023.","DOI":"10.3389\/fimmu.2023.1221125"},{"key":"1844_CR4","doi-asserted-by":"crossref","unstructured":"K\u00e4llberg H, et\u00a0al. Gene-gene and gene-environment interactions involving HLA-RD1, PTPN22, and smoking in two subsets of RA. Am J Hum Genet. 2007.","DOI":"10.1086\/516736"},{"key":"1844_CR5","unstructured":"Klareskog L, et\u00a0al. The evolution of rheumatoid arthritis: past, present and future. Archives of Rheumatic Diseases. 2009."},{"key":"1844_CR6","doi-asserted-by":"crossref","unstructured":"Gwinnutt JM, et\u00a0al. 2021 EULAR Recommendations Regarding Lifestyle Behaviours and Work Participation to Prevent Progression of RMDs. Ann Rheum Dis. 2023.","DOI":"10.1136\/annrheumdis-2021-222020"},{"key":"1844_CR7","doi-asserted-by":"crossref","unstructured":"Sch\u00e4fer C, Key\u00dfer G. Lifestyle Factors and Their Influence on Rheumatoid Arthritis: A\u00a0Narrative Review. Journal of Clinical Medicine. 2022.","DOI":"10.3390\/jcm11237179"},{"key":"1844_CR8","unstructured":"STOP-RA: Deane KD, et\u00a0al. Hydroxychloroquine for the Prevention of Rheumatoid Arthritis (STOP-RA): A\u00a0Randomized Trial. Arthritis & Rheumatology. 2025."},{"key":"1844_CR9","unstructured":"TREAT EARLIER: Krijbolder DI, et\u00a0al. Intervention with methotrexate in patients with arthralgia at risk of RA: a\u00a0randomised trial. Lancet. 2022."},{"key":"1844_CR10","doi-asserted-by":"crossref","unstructured":"PRAIRI: Gerlag DM, et\u00a0al. Effects of B\u2011cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study. Ann Rheum Dis. 2019.","DOI":"10.1136\/annrheumdis-2017-212763"},{"key":"1844_CR11","unstructured":"APIPPRA: Cope AP, et\u00a0al. Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a\u00a0randomised trial. Lancet. 2024."},{"key":"1844_CR12","doi-asserted-by":"crossref","unstructured":"ARIAA: Rech J, et\u00a0al. Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA). Lancet. 2024.","DOI":"10.1016\/S0140-6736(23)02650-8"},{"key":"1844_CR13","unstructured":"ALTO (APIPPRA Long-term): Cope AP, et\u00a0al. Arthritis-free survival 4\u00a0years after a\u00a01-year course of abatacept in citizens at risk of RA. Lancet Rheumatology. 2026."},{"key":"1844_CR14","unstructured":"ARIAA Long-term \/ Harre: Harre U, et\u00a0al. Long-term follow-up of ARIAA: IgA-ACPA status predicts RA-free time after abatacept. Lancet Rheumatology. 2026."},{"key":"1844_CR15","doi-asserted-by":"crossref","unstructured":"Matthijssen XME, et\u00a0al. Tenosynovitis Has a\u00a0High Sensitivity for Early ACPA-positive and ACPA-negative RA. Ann Rheum Dis. 2021.","DOI":"10.1136\/annrheumdis-2021-eular.180"},{"key":"1844_CR16","unstructured":"Brink M, Rantap\u00e4\u00e4-Dahlqvist S. Time of appearance of different autoantibodies before the onset of rheumatoid arthritis. Ann Rheum Dis. 2021."},{"key":"1844_CR17","doi-asserted-by":"crossref","unstructured":"Abacar K, et\u00a0al. Quantitative MRI Tenosynovitis Volume Explains the Association Between Tendon Involvement and Future RA. Ann Rheum Dis. 2026.","DOI":"10.1016\/j.ard.2025.10.020"},{"key":"1844_CR18","unstructured":"van Steenbergen HW, et\u00a0al. EULAR\/ACR Risk Stratification Criteria for Development of RA in the Risk Stage of Arthralgia. Arthritis & Rheumatology. 2026."},{"key":"1844_CR19","doi-asserted-by":"crossref","unstructured":"Nieuwenhuis WP, et\u00a0al. Evaluation of the Diagnostic Accuracy of Hand and Foot MRI for Early Rheumatoid Arthritis. Rheumatology. 2017.","DOI":"10.1093\/rheumatology\/kex167"},{"key":"1844_CR20","unstructured":"den Hollander NK, et\u00a0al. Hand and Foot MRI in Contemporary Undifferentiated Arthritis. Rheumatology. 2022."},{"key":"1844_CR21","doi-asserted-by":"crossref","unstructured":"Aletaha D, Smolen JS. Diagnosis and Management of Rheumatoid Arthritis: A\u00a0Review. JAMA. 2018.","DOI":"10.1001\/jama.2018.13103"},{"key":"1844_CR22","unstructured":"M\u00fcller F, et\u00a0al. CAR T\u2011cell treatment of systemic lupus erythematosus, idiopathic inflammatory myositis, and systemic sclerosis. NEJM. 2024."}],"updated-by":[{"DOI":"10.1007\/s00393-026-01856-8","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000}}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-026-01844-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-026-01844-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-026-01844-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:20:56Z","timestamp":1785943256000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-026-01844-y"}},"subtitle":["Von der Prim\u00e4rpr\u00e4vention zur medikament\u00f6sen Interzeption","From primary prevention to targeted drug interception"],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1844"],"URL":"https:\/\/doi.org\/10.1007\/s00393-026-01844-y","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"29 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Die originale Onlineversion dieses Artikels wurde korrigiert: Abb. 1 war fehlerhaft. Dar\u00fcber hinaus wurde in der Legende auf die falsche Datenquelle verwiesen.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Erratum","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Zu diesem Beitrag wurde ein Erratum ver\u00f6ffentlicht:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00393-026-01856-8","URL":"https:\/\/doi.org\/10.1007\/s00393-026-01856-8","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.\u00a0Rech gibt an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","label":"Interessenkonflikt","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}}]}}